Uroeze 400 Tablets

This page contains information on Uroeze 400 Tablets for veterinary use.
The information provided typically includes the following:
  • Uroeze 400 Tablets Indications
  • Warnings and cautions for Uroeze 400 Tablets
  • Direction and dosage information for Uroeze 400 Tablets

Uroeze 400 Tablets

This treatment applies to the following species:
Manufacturer: Virbac

Each Scored Tablet Contains: Ammonium Chloride 400 mg in a palatable protein base.

INDICATION: For use as a urinary acidifier in cats and dogs.

Uroeze 400 Tablets Caution

Federal law (USA) restricts this drug to use by or on the order of a licensed veterinarian.

DOSAGE: The suggested dosage of Uroeze Tablets for adult cats and dogs is 1/2 to 1 tablet per 10 lbs (4.5 kg) body weight twice daily with food. Daily dose may vary with different diets depending on alkalinity of diet. Dosage should be adjusted to maintain urine pH consistently below 6.6. Not intended for use in kittens.

Warning

Do not administer to animals with severe liver or kidney damage or to animals exhibiting acidosis.

Uroeze 400 Tablets Caution

May cause gastric mucosal irritation.

KEEP THIS AND ALL MEDICATIONS OUT OF THE REACH OF CHILDREN.

STORE AT CONTROLLED ROOM TEMPERATURE OF 15°-30°C (59°-86°F).

Do not dispense in 500-tablet container.

Mfg. by: Virbac AH, Inc., P.O. Box 162059, Fort Worth, TX 76161

(800) 338-3659

 

NDC

ID#

 

100 TABLETS

051311-854-10

854100

301601-02

500 TABLETS

051311-854-50

854500

301602-02

NAC No.: 10231080

VIRBAC ANIMAL HEALTH
Virbac Corporation

P.O. BOX 162059, FORT WORTH, TX, 76161
Telephone:   817-831-5030
Order Desk:   800-338-3659
Fax:   817-831-8327
Website:   www.virbacvet.com
Every effort has been made to ensure the accuracy of the Uroeze 400 Tablets information published above. However, it remains the responsibility of the readers to familiarize themselves with the product information contained on the US product label or package insert.

Copyright © 2014 North American Compendiums. Updated: 2014-05-28

(web3)